Conditions: Multiple Sclerosis Relapsing-Remitting
Keywords: Relapsing remitting multiple sclerosis Fingolimod FTY720
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 42
Healthy volunteers: no

Brief summary:
The study will assess the patients' satisfaction of treatment after 12 months treatment with fingolimod It also will assess the tolerability profile of fingolimod in a small population.

Detailed description:

Arms:
arm 1: Patients received fingolimod 0.5 mg oral capsules daily with or without food.

Interventions: intervention 1: Fingolimod
Intervention descriptions: intervention 1: Fingolimod 0.5mg orally once a day without food.

Protocol document: